Minerva Neurosciences Statistics

Total Valuation

NERV has a market cap or net worth of $282.34 million. The enterprise value is $258.29 million.

Market Cap	282.34M
Enterprise Value	258.29M

Important Dates

The next estimated earnings date is Friday, May 1, 2026, before market open.

Earnings Date	May 1, 2026
Ex-Dividend Date	n/a

Share Statistics

NERV has 43.84 million shares outstanding. The number of shares has increased by 11.75% in one year.

Current Share Class	43.84M
Shares Outstanding	43.84M
Shares Change (YoY)	+11.75%
Shares Change (QoQ)	+46.89%
Owned by Insiders (%)	0.64%
Owned by Institutions (%)	28.42%
Float	25.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 36.28

Current Ratio	36.28
Quick Ratio	35.93
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-13.97%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-15.79%
Weighted Average Cost of Capital (WACC)	2.56%
Revenue Per Employee	n/a
Profits Per Employee	-$41.92M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +265.91% in the last 52 weeks. The beta is -0.21, so NERV's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	+265.91%
50-Day Moving Average	6.54
200-Day Moving Average	4.11
Relative Strength Index (RSI)	50.74
Average Volume (20 Days)	205,821

Short Selling Information

The latest short interest is 1.16 million, so 2.64% of the outstanding shares have been sold short.

Short Interest	1.16M
Short Previous Month	1.02M
Short % of Shares Out	2.64%
Short % of Float	4.59%
Short Ratio (days to cover)	2.88

Income Statement

Revenue	n/a
Gross Profit	-5.76M
Operating Income	-15.10M
Pretax Income	-293.42M
Net Income	-293.42M
EBITDA	-15.10M
EBIT	-15.10M
Earnings Per Share (EPS)	-$34.67

Full Income Statement

Balance Sheet

The company has $82.30 million in cash and $60.00 million in debt, giving a net cash position of $22.30 million or $0.51 per share.

Cash & Cash Equivalents	82.30M
Total Debt	60.00M
Net Cash	22.30M
Net Cash Per Share	$0.51
Equity (Book Value)	-135.79M
Book Value Per Share	-3.25
Working Capital	80.81M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-13.51M
Capital Expenditures	n/a
Depreciation & Amortization	5,442
Net Borrowing	n/a
Free Cash Flow	-13.51M
FCF Per Share	-$0.31

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NERV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.75%
Shareholder Yield	-11.75%
Earnings Yield	-104.57%
FCF Yield	-4.82%

Analyst Forecast

The average price target for NERV is $10.50, which is 63.04% higher than the current price. The consensus rating is "Buy".

Price Target	$10.50
Price Target Difference	63.04%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 21, 2022. It was a reverse split with a ratio of 1:8.

Last Split Date	Jun 21, 2022
Split Type	Reverse
Split Ratio	1:8

Scores

Altman Z-Score	n/a
Piotroski F-Score	2